SpyGlass IOL

DEVICE3 trials

Sponsors

SpyGlass Pharma, Inc.

Conditions

CataractGlaucomaOcular Hypertension

Phase 1

Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution

Active, not recruitingNCT06120842

SpyGlass Pharma, Inc.Cataract, Glaucoma, Ocular Hypertension

Start: 2023-10-13End: 2027-11-30Updated: 2025-08-22

Phase 3

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

RecruitingNCT07218783

SpyGlass Pharma, Inc.Cataract, Glaucoma, Ocular Hypertension

Start: 2025-10-15End: 2031-03-31Target: 400Updated: 2025-10-20

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

RecruitingNCT07218796

SpyGlass Pharma, Inc.Cataract, Glaucoma, Ocular Hypertension

Start: 2025-10-28End: 2031-05-31Target: 400Updated: 2025-10-20